dilution

adcom

Ardelyx Inc

approval

$ARDX what fucking morons are selling it’s approved there are some real dumb fucks involved in this stock good let them get the fuck out. Pussys

$ARDX if we have no approval  you know they are corrupt. .

$ARDX with a 98% chance of fda approval within a few weeks, what is this crap?

Denial of approval of such product  will need a strong justification or presence of significant risk (which is not applicable for Tenapanor as elaborated in the above detailed  
analysis).

but not expecting a ton of juice upon approval 🤞

$ARDX with all due respect, this price action today is embarrassing…nasdaq up 6% we can’t even break $1.30 embarrassing for real… I won’t even be surprised if we get approval next week and we stay stagnant for a bit.

The issue raised was probably one of the only negatives for approval:  The fact that we are using &#39;surrogate&#39; endpoints rather than the correlated clinical outcome.

Tena is already approved for IBS with a solid safety profile, and phosphorus management is a real issue in the CKD community with only binders being available.

insider

One red flag in this company, despite one director buying 1m worth recently, is the low insider ownership.

$ARDX less than one dollar soon insiders doing, given how corrupt the board and CEO are .

$ARDX company doesn’t say anything, insiders don’t buy, stock trades like total crap.

Kind of thing you expect to happen to a stock if the CEO is complicit in a INSIDER Trading SCHEME. .

patient

Those laxatives your taking are not working, you need the full Fleets treatment, a complete system flush.

I still remember listening to the meeting and getting mad at Alikhani, the so called patient&#39;s advocate.

The subsequent increase in intraluminal pressure leads to decreased intestinal blood flow, and in the case of our patient, intestinal ischemia.

They got something that improve the quality of life for dialysis patients and you guys called the trash company.

$ARDX&quot; I am a board-certified nephrologist for 30 years and was very disappointed to say the least by the denial of application of Tenapanor for hyperphosphatemia in patients with CKD.

However, the enrichment strategy did not appear to reliably identify patients who would have a larger treatment response to tenapanor.

As you think about your decision, I’d like to ask you to remember me and the other patients out there like me who are looking for solutions to help them.

Company sitting on the best fundamentals ever to date and we get treated to these stupid 1 liner worthless post.

However when patients get discharged compliance will still remain an issue because nurses and doctors aren’t there watching over them and making sure they take their meds.

trading

Obvious, as hell looking at tape today this trading was far from organic.

↳ Why are you paying to be in a Trading Room?

$ARDX 
With these absurd disconnected 80-100million-share volumes, trading price purely a construction of Dark pool, HFT, MM share-swapping, etc.

In the scientific community as well as in trading feeling get fucked.

reason

what a BS TREE SHAKE by MM&#39;s today was zero reason to let this drop like they did. .

I see no reason to hold or add at this point.

There would be no other reason for the timing.

$ARDX Ok, the only reason to deny our drug is negligible efficacy.

but that the FDA had denied access to for reasons no one understood.

Must be the reason this can’t get past 1.5

There is no reason for it to fall today like this!

He is one of the reasons that the SP stays down.

Doubled in size and reduced cash burn with no risk of dilution.

$ARDX incredible resilience in the face of dilution.

$ARDX With the dilution being announced and baked in now, there is no risk left here.

$ARDX this is holding up nicely for news of potential 40% dilution

Dilution to launch TWO global drugs is money well spent.

This was a much better road then the R/S.

$ARDX I am thrilled that the chairwoman of our Adcom gave monotherapy a thumbs up.

So glad that I bought before ADCOM meeting.

$ARDX cytk failed Adcom yesterday, and went up! 😆

For the ADCOM had cast their votes, and they were overwhelmingly positive.

ADCom approval big + 
2. Insider spent 1M on buying shares at 1.75$ 
3.

$ARDX  We saw 1 leg, and nice consolidation today, post adcom.

With a positive adcom that occurred you are golden adding anything under $3.

All in all with the Adcom, insider buy and how Ibsrela is doing looking good here.

I am confident the AdCom will vote in favor of approval.

$ARDX Ready for a very nice ending to ADCOM meeting..

news

$ARDX Looking good, would be nice to finish the day in the 4&#39;s 
 
Still waiting on positive news from the company.

$ARDX very good fda news on this conference call

$ARDX just keeps doing things well, and good news should arrive soon!

If the trend of script numbers is anything to go by, guidance could be way better than Wall Street expects giving us a nice boost before FDA news.

$ARDX LOL, soon Xenopah News  😁 
Stay in, or buy

$ARDX good news coming man let’s goooooo

$AKBA within 3  to 4 weeks this stock could be over 2 heading to three like $ARDX .. gsk approval has helped.. fda news, ema opinion/ approval, partnership..

application

This is 100% normal and part of the growth of a strong company with excellent fundamentals and an FDA approval coming this year.

Better than money in the bank with soon resubmission and approval 2-6 months later!

And this is just a beginning, FDA approval will take it to the skies.

Pretty Bullish ER going to give us an update on FDA when and etc. .

$ARDX This company is sitting on a mountain of great fundamentals.. 40++ medical patents ,,, 40+ more in application status 1 drug approved IBSRELA 1 drug almost aproved XPHOZAH a kidney drug that could pull an annual billion dollar + revenue.

bull

🎉

Have a great evening bulls and longs. 🍻🍻🍻

Hold strong bulls we’re not going anywhere 😤

$ARDX I’ll see you bulls in the 3.90s today 😤

$ARDX wow and just like that there’s no more bulls 🤣🤣🤣

A close above 4 will be huge for the bulls

Cheers and see you all tomorrow bulls and longs. 🍻

$ARDX  Looks like a bull flag on the daily morning here.

$ARDX $APRN $BLBX Have a great night, Bulls and Bull-ettes! !

Panbela Therapeutics Inc

I’m afraid there are too many Bots &amp; Wimps posting on S/T.

$PBLA High risk of further dilution after the split, de-listing &amp; bankruptcy soon!

F*cking horrible company &amp; management.

$1.3 million on general administration &amp; $2.3 million on R&amp;D. Pretty the PO Box that they use at the local UPS store doesn&#39;t cost that much!

They should legally &amp; criminally be held liable.

CEO, executives &amp; board need to be held accountable!

$PBLA This company is nearly worthless and solely exists to be used as an ATM for the executives &amp; board!

Horribly managed company with greedy executives &amp; board.

wall

Then they put their silly wall getting people even more panicked!

$PBLA in all homesty, 20 cents in ah is possible, walls are paper thin

joke

but on pipeline and outlook cancer trials in tage 3 and 4 million MK what a joke DO NOT SELL NOW I PLEA YOU

It’s just ridiculous that “good news” through out the month took it from 1.25 to 0.78

$PBLA Orphan drug status for their cancer treatment has been granted in the EU only 2 weeks ago…based on the facts current valuation is absolutely ridiculous !

been a quietly ridiculous day actually haha

spike

SPIKE , DROp, DRop, Drop, drop,SPIKE , DROp, DRop, Drop, drop,SPIKE , DROp, DRop, Drop, drop

$PBLA this coulda done so much better today even after that morning spike

$PBLA i just went  through this several times at $TCBP and $GMVD people telling me theyd never bounce off of spikes and they KEEP bouncing.

candlestick

4h chart looks Great and recent R/S puts it at 900k float total.

$PBLA a lot of times after the r/s companies announce some nice news $PALI for example and it’s news of expedited fda … glad to see  it coming  riding into the r/s  sunset

Given PBLA recent phase trials news, I expect this to gain a decent volume and spike up after the R/S.

$COSM based on the R/S trend we could see a positive day $PBLA

$PBLA $PLX $GMDA $OCGN check out $CDTX pdufa March 22nd (ADCOM favor 14-1) , offering done , milestone payment ahead 
Many positive news 💎💎💎

$PBLA I love the bulls that continue to say, bottom is here, it can’t go any lower… lmao!

$PBLA Bulls your patience &amp; ignorance has been rewarded!

This is going to melt so many faces and will give bulls 300%&lt; gains and possible much more.

$PBLA sell the great news and great earnings. .yay

Earring h expected -$3.7 I think they will beat it combine it with some more news and 💥

$PBLA This will open the next few days at $1.5 
News runs 😎

$PBLA So, good news today with patient enrolment begin on yet another trial.

$PBLA Ooh baby..nice news for this sick azz low floater.

In contrary we had good news after other last week.

volume

$PBLA Already 500K over the 10 day volume average, seems to have people interested today.

$PBLA volume today is pretty amazing I must say.

🚨Relative Volume Increase🚨 Part 2

$SGTX $SINT $ZEST $WTER $PBLA 

Stay tuned for more ideas!

$PBLA  PBLA SHORT VOLUME UP TO 71% IS A GOOD SIGNAL

$LMFA Volume has been ascending and can 5-10X.

KemPharm Inc

If the current staff is not able to get the job done, why are we still paying them?

but sho nuff in a mood about Corium not doing their job.

but still seeing plenty of reports of Azstarys availability issues at pharmacies (Coriums job).

KEEP YOUR FOCUS ON AZSTARYS AND DO YOUR DAMN JOB.

$KMPH Honest question, who keeps their high paying job and salary when you continually fail to deliver to share holders?

He’s done a bang-up job for them while shuttle cocking us!

$KMPH Richard Pascoe should be immediately fired from his phony do nothing job at Kempharm.

But yeah Corium and it&#39;s sales reps suck and are doing a bad job.

But I thought Travis was doing a good job?? !

hand

Warrants/Option have been handed out like candy on Halloween, decreasing shareholder value.

In mentioning the changes and additions, I noticed he didn&#39;t mention all these options/warrants they handed out reducing shareholder value.

We hand it over to Corium and they completely drop the ball and sales suck.

I went all in on kmph, and for the first time in a while, I don&#39;t feel great about the cards in my hand.

Create a new position or something to hand hold Perrys dumbass through this.

$KMPH Too bad Azstarys isn’t a schedule 19 drug, KemPharm could REALLY hand out their medications today 😁

$KMPH I think it’s hysterical that The Board stated that they bring quality &amp; experience meanwhile the truth shows another picture.

but too small (market cap &amp; volume wise) for me

Please send Travis &amp; Laduane to investor presentation school or get someone on the call who gets importance of presentation.

Travis sounded like he was underwater and hungover, LaDuane sounded sheepish, and the Q&amp;A was like a sprint.

So far board &amp; mgmt have proven weak.

$KMPH too many whiners &amp; bitches here

business-result

Maybe you should have put out a disclaimer that past  performance does not indicate future results?

The top line results were written in scientific gibberish.

If NDA submission was next quarter no one would be selling off before that catalyst. Disappointing.

$KMPH 
We need better results from Corium- NOW.

Two more quarters is a hard turkey to swallow when you’ve been waiting 14. #annualholidaymicklecuck

Unfortunately  the boost for KMPH is nullified by Travis&#39;  extension of 2 more quarters of dullness

This is a 2 quarter delay, that definitely sucks,

But  at this moment it is hard for me to accept the fact that we are delayed by 2 quarters.

product

Crappy calls are a by product of all this.

Told you this was dead money with that horrible management team and generic product.

Gotta make sure they not jacked up on their own product!

Regardless of SP at this moment, it does feel good to be invested in a bio stock with high possibility upside and no fear of a 25-30% dump on dilution. ..

ARDX got a very difficult ADCOM and still came out winning.

but for the majority of time they will follow the Adcom recommendation ✌️

growth

Add in a little growth, and Zevra is in the black by Q4.

The manufacturing, marketing and distribution ARE in place and the script numbers ARE showing very solid growth.

$KMPH Quite impressive growth in scripts!

This is the script growth I&#39;ve been waiting for.

$KMPH This week we have MoM script growth, 24%, and YoY script growth, 748%. Nice!

New treatments and product launches: The development and launch of new and innovative treatments for ADHD, such as extended-release formulations and combination products, is also driving market growth.

No wonder we are seeing the exponential sales growth! !

The good news is that once our catalysts hit, this will all be water under the bridge ✌🏻

$KMPH https://twitter.com/zevratx/status/1629141771887300616?s=46&amp;t=mKynV6sCCjZ8XQfM2ymhxA

Great news!! !

Nevertheless good news, as it means the previous script number wasn&#39;t an outliner in the other direction either.

however like $KMPH all good news as a company with tons of potential.

And 4 year study is complete that&#39;s great news.

market

The market futures (so far) are looking positive on a Monday?

I am pleased with the SP! !🫡
(Especially on a Red Market day)

Good thing the market as a whole is thriving today, 🤣.

This will be a winner take all market and it feels good to have chosen the right horse.

but now we have new market conditions we can only dream about.

$kmph Jumped back i pre market for 1k starter 5.40&#39;s  scripts this week are a blowout!

$KMPH Well if the market is voting on hires Gallo is a 👍 😂

but I also believe the market is full of opportunities nowodays.

ARDX

Ardelyx Inc

23.58%

$3.35 - $4.14

Mar, 12, 2023

Jan, 24, 2023

PBLA

Panbela Therapeutics Inc

-63.19%

$1.44 - $0.53

Jan, 21, 2023

Jan, 18, 2023

KMPH

KemPharm Inc

-26.64%

$5.63 - $4.13

Nov, 4, 2022

ARDX

Ardelyx Inc

23.58%

$3.35 - $4.14

Mar, 12, 2023

Jan, 24, 2023

Jan, 19, 2023

Jan, 19, 2023

Jan, 19, 2023

Jan, 19, 2023

Nov, 14, 2022

PBLA

Panbela Therapeutics Inc

-63.19%

$1.44 - $0.53

Jan, 21, 2023

Jan, 18, 2023

Jan, 13, 2023

Jan, 12, 2023

Jan, 10, 2023

KMPH

KemPharm Inc

-26.64%

$5.63 - $4.13

Nov, 4, 2022